KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer
Conditions: Breast Cancer; Gastric/Gastroesophageal Junction Cancer Intervention: Drug: KN026 Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Research